Please login (Members) to view content or
(Nonmembers) this article.
No votes yet
ONS Guidelines Article

Lymphedema: Clinical Summary of the ONS Guidelines™ for Cancer Treatment–Related Lymphedema

Chelsea Backler
Marcia Beck
Ellen Poage
CJON 2020, 24(5), 566-570 DOI: 10.1188/20.CJON.566-570

Secondary (acquired) lymphedema is a chronic condition lacking a known cure that most commonly results from cancer treatment, particularly for breast, gynecologic, prostate, and head and neck cancers; lymphoma; and melanoma, and affects an estimated 1 in 1,000 Americans. Lymphedema is characterized by an accumulation of protein-rich lymphatic fluid in the affected part of the body. It can potentially affect functioning, family roles and relationships, occupational roles, and productivity. The majority of strategies to prevent and manage lymphedema are nonpharmacologic, used alone or in combination with one another.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or